- Founded
- 2018
- Employees*
- 1-10
- Funding to Date*
- $250K
- Website
- asimica.com
Biofermentation is often done in batches, because the cells (bacteria, yeast, etc.) that produce the product of interest will eventually mutate and cause the entire batch to become unproductive. This is why batches have to restart, undergoing an idle period, which costs time and money in labor and lost productivity.
Asimica’s solution to this problem is to create microbial stem cells, a technology that constantly generates “young” and productive factory cells, which solves two problems: 1) it prolongs the lifespan of a batch, which means more productivity and less downtime, and 2) more productivity from the constant production of younger factory cells. This can increase the productivity of biofermentation 2-3X per batch.